Payton Nyquvest

Payton is the founder and CEO of Numinus. Prior to Numinus he served in multiple positions with Mackie Research Capital, Jordan Capital Markets, and Canaccord Financial.

Numinus to sell five Utah ketamine clinics to Stella for $3.5M in tech pivot
Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) agreed to sell its five Utah clinics to psychiatric care provider Stella. The deal will also create a...
Numinus to sell five Utah ketamine clinics to Stella for $3.5M in tech pivot Article
Nov 15, 2024
Investors rally behind Numinus Wellness in a $6M bought deal
Numinus Wellness Inc. (OTCQX: NUMIF) entered into a agreement to raise $6 million through a bought deal with Eight Capital and a syndicate that includes...
Investors rally behind Numinus Wellness in a $6M bought deal Article
Feb 02, 2024
Navigating the Psychedelic Landscape: Q3 Psychedelic Industry Report
Psychedelic Industry Quarter Review and HighlightsPsychedelic ScienceSurveysResearchClinical TrialsMAPSRegulations and PoliticsUSStatesCanadaInternationalEvents & MediaBusinessCapitalStocks M&AQ3 Review and Highlights This past quarter has been, without a doubt, the...
Navigating the Psychedelic Landscape: Q3 Psychedelic Industry Report Article
Oct 23, 2023
Q3 Overview: The State of the Psychedelic Sector
This past quarter has been, without a doubt, the busiest and most transformative three months of this year— perhaps even of the entire history of...
Q3 Overview: The State of the Psychedelic Sector Article
Oct 13, 2023
Clinic Appointments Give Numinus Rosy Outlook on Expansion - Green Market Report
With MDMA-assisted therapy's possible approval, the company is preparing to meet demand with more practitioners and wellness clinics.
News
Jul 27, 2023
Numinus Launches the Practitioner Certification Pathway – a Complete Psychedelic-Assisted Therapy Training Program
Numinus Wellness Inc (TSX: NUMI / OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it...
Numinus Launches the Practitioner Certification Pathway – a Complete Psychedelic-Assisted Therapy Training Program Article
Mar 27, 2023
Numinus CEO Payton Nyquvest On Transforming Healthcare With Psychedelics
Numinus focused on profitability and service providers offering various psychedelic therapies. Possible FDA approval of MDMA a huge catalyst.
News
Mar 05, 2023
Music as Medicine - Music's Role in Mental Health & Psychedelic Therapy | Payton Nyquvest
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes ...
News
Jun 21, 2022
Music as Medicine – Music’s Role in Mental Health & Psychedelic Therapy | Payton Nyquvest
In this segment of Spotlight In Focus, Psychedelic Spotlight’s Matthew Dunehoo discusses the importance of music in alleviating mental health illnesses with Numinus Wellness CEO...
Article
Jun 21, 2022
CEO Payton Nyquvest Speaks Out on News: Numinus Wellness Acquires Novamind
... research facilities and a dedicated psychedelics research lab. ... we see value being created within the psychedelic space,” Nyquvest says.
News
Jun 14, 2022

Last updated: Sep 26, 2022
Request Deletion